Claritev Corporation (CTEV) Stock Score, Valuation & Financial Research
Claritev Corporation is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 17/100.
Quick answer for CTEV
Claritev Corporation currently has a Wall Street Score of 17/100. The stored market price is $33.56. Its financial score is 20/100. Its valuation score is 0/100. The latest WSS change is +0.3 points. These figures are a research snapshot, not a buy or sell recommendation.
What Claritev Corporation does
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to iden
CTEV financial snapshot
- Wall Street Score:
- 17/100
- Current price:
- $33.56
- Market capitalization:
- $572.1M
- Revenue:
- $994.7M
- Net income:
- $-283.1M
- Free cash flow:
- $-12.3M
- Cash:
- $14.4M
- Total debt:
- $4.62B
- EPS:
- -17.01
- Financial score:
- 20/100
- Valuation score:
- 0/100
- Revenue score:
- 21/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $-12.3M, showing cash burn in the current stored period.
- The balance sheet shows $14.4M of cash versus $4.62B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.3 points: CTEV increased 0.3 points because Revenue improved by 2.2 points.
- The current research record carries a severe debt stress warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 20/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-17.
How to research CTEV
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.